quinidine has been researched along with bupranolol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Kalow, W; Muller, R; Pressacco, J | 1 |
2 other study(ies) available for quinidine and bupranolol
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Interactions of bupranolol with the polymorphic debrisoquine/sparteine monooxygenase (CYP2D6).
Topics: Binding, Competitive; Bupranolol; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Humans; In Vitro Techniques; Microsomes, Liver; Mixed Function Oxygenases; Oxidation-Reduction; Quinidine; Sparteine; Stereoisomerism | 1993 |